S. Kirwan

发表

Methodological Considerations in Evaluating Long-Term Systems Change

P. Pradhan, D. Seddon, Meeta S. Pradhan, 2016 .

A training needs analysis of mental health nurses knowledge and application of the Mental Health Act 2001 which will inform the development of education and training workshops across the hospital.

S. Kirwan, 2016 .

A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents.

C. Shelburne, H. Staats, S. Abraham, 2013, MedChemComm.

Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

W. M. Foster, H. Staats, D. Briles, 2010, Vaccine.

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.

H. Staats, M. Gunn, S. Abraham, 2013, Vaccine.

In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity

B. Haynes, S. Alam, R. Scearce, 2007, Infection and Immunity.

Stable dry powder formulation for nasal delivery of anthrax vaccine.

Anthony J Hickey, H. Staats, A. Hickey, 2012, Journal of pharmaceutical sciences.

Development of a Bead Immunoassay To Measure Vi Polysaccharide-Specific Serum IgG after Vaccination with the Salmonella enterica Serovar Typhi Vi Polysaccharide

D. Wagener, P. Majumder, J. Stephenson, 2010, Clinical and Vaccine Immunology.

Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines.

H. Staats, James W. Peacock, S. Nordone, 2006, AIDS research and human retroviruses.

Development of a Bead Immunoassay To Measure Vi Polysaccharide-Specific Serum IgG after Vaccination with the Salmonella enterica Serovar Typhi Vi Polysaccharide

D. Wagener, P. Majumder, J. Stephenson, 2010, Clinical and Vaccine Immunology.